U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
425
Substance Class Protein
Created
by admin
on Mon Mar 31 20:09:37 GMT 2025
Edited
by admin
on Mon Mar 31 20:09:37 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Record UNII
YI437801BE
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
MOGAMULIZUMAB (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
MOGAMULIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
KM8761
Code English
Mogamulizumab [WHO-DD]
Common Name English
MOGAMULIZUMAB [USAN]
Common Name English
KM-8761
Code English
MOGAMULIZUMAB [MI]
Common Name English
KW-0761
Code English
AMG-761
Code English
MOGAMULIZUMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
MOGAMULIZUMAB [JAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(CC CHEMOKINE RECEPTOR CCR4) (HUMAN-MOUSE MONOCLONAL KW-0761 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL KW-0761 .KAPPA.-CHAIN, DIMER
Common Name English
mogamulizumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
EU-Orphan Drug EU/3/16/1756
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
WHO-ATC L01XC25
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
FDA ORPHAN DRUG 322010
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
FDA ORPHAN DRUG 345311
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
FDA ORPHAN DRUG 313710
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1743041
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
RXCUI
2054077
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
ALTERNATIVE
CAS
1159266-37-1
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
DRUG CENTRAL
5031
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
DAILYMED
YI437801BE
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
SMS_ID
100000139237
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
FDA UNII
YI437801BE
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
JAPANESE REVIEW
POTELIGEO
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY APPROVED MARCH 2012
MERCK INDEX
m11705
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
LACTMED
Mogamulizumab
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
WIKIPEDIA
MOGAMULIZUMAB
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
INN
9374
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109340
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
RXCUI
2054068
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
NCI_THESAURUS
C62510
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
EVMPD
SUB85518
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
IUPHAR
6477
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
USAN
XX-20
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
EVMPD
SUB77002
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
DRUG BANK
DB12498
Created by admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
PRIMARY
From To
1_22 1_96
1_146 1_202
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_263 2_323
2_369 2_427
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
1_222 3_219
2_222 4_219
1_228 2_228
1_231 2_231
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
MOGAMULIZUMAB-KPKC
INNOVATOR->PARENT
C-C CHEMOKINE RECEPTOR TYPE 4
TARGET -> INHIBITOR
MOGAMULIZUMAB-KPKC
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
MOGAMULIZUMAB
ACTIVE MOIETY

Physical Modifications

Modification Role Parameter Name Amount
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966